Literature DB >> 18997462

Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome.

Lidia Santarpia1, Francesca Catanzano, Margherita Ruoppolo, Lucia Alfonsi, Dino Franco Vitale, Rita Pecce, Fabrizio Pasanisi, Franco Contaldo, Francesco Salvatore.   

Abstract

Plasma citrulline is known to be a marker of absorptive enterocyte mass in humans. We evaluated whether citrulline and other blood amino acids are indicators of residual small intestinal length and therefore potential predictors of dependence on parenteral nutrition in the long term. We studied 25 patients with short bowel syndrome (SBS) after at least 18 months since last digestive circuit modification; 24 of them were again evaluated 1 year later. Ten patients were weaned off parenteral nutrition and 15 were dependent on parenteral nutrition. Fifty-four healthy volunteers (28 women and 26 men) served as controls. Amino acid levels were determined on serum with high-performance liquid chromatography (HPLC) as well as on blood and serum with tandem mass spectrometry analysis. Five amino acids (citrulline, leucine, isoleucine, valine and tyrosine) were significantly lower in all SBS patients than in controls, whereas glutamine, measured only by HPLC, was significantly higher. Nevertheless, only serum citrulline measured with HPLC was significantly related to small bowel length. We conclude that HPLC remains the reference methodology to evaluate blood or serum amino acid levels in adult population with SBS. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18997462     DOI: 10.1159/000170888

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  3 in total

1.  Consumption of pasteurized human lysozyme transgenic goats' milk alters serum metabolite profile in young pigs.

Authors:  Dottie R Brundige; Elizabeth A Maga; Kirk C Klasing; James D Murray
Journal:  Transgenic Res       Date:  2009-10-22       Impact factor: 2.788

2.  Effect of Teduglutide, a Glucagon-like Peptide 2 Analog, on Citrulline Levels in Patients With Short Bowel Syndrome in Two Phase III Randomized Trials.

Authors:  Douglas L Seidner; Francisca Joly; Nader N Youssef
Journal:  Clin Transl Gastroenterol       Date:  2015-06-25       Impact factor: 4.488

3.  Label-Free Quantitative Proteomics in a Methylmalonyl-CoA Mutase-Silenced Neuroblastoma Cell Line.

Authors:  Michele Costanzo; Armando Cevenini; Emanuela Marchese; Esther Imperlini; Maddalena Raia; Luigi Del Vecchio; Marianna Caterino; Margherita Ruoppolo
Journal:  Int J Mol Sci       Date:  2018-11-13       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.